Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction

David E. Mosedale, Duncan Smith, Sri Aitken, Peter M. Schofield, Sarah C. Clarke, Duncan McNab, Hester Goddard, Catharine R. Gale, Christopher N. Martyn, Hugh W L Bethell, Caryl Barnard, Sarah Hayns, Claire Nugent, Annik Panicker, David J. Grainger

Research output: Contribution to journalArticle

Abstract

The chemokines are a family of signalling proteins that participate in regulation of the immune system and have been implicated in the pathogenesis of vascular diseases. Deleting the gene encoding the chemokine MCP-1 in mouse models of atherosclerosis reduces lipid lesion formation and circulating chemokines are upregulated in man immediately following myocardial infarction (MI) or coronary angioplasty. We have therefore investigated whether circulating levels of two chemokines (MCP-1 and eotaxin) differ between subjects with and without atherosclerosis. We have used three different methods of measuring the presence and extent of atherosclerosis in human subjects: duplex ultrasonography of the carotid arteries and clinical diagnosis of coronary heart disease on individuals from the general population and coronary angiography on patients with suspected heart disease. There was no difference in the levels of circulating MCP-1 or eotaxin, measured by ELISA, between subjects with and without atherosclerosis. Furthermore, any increase in circulating MCP-1 following acute MI must be short-lived, since chemokine levels were not different in subjects who had had an MI previously compared to those who had not. We conclude that although there may be a transient increase in circulating chemokine levels following coronary angioplasty, there is no difference in the levels of circulating MCP-1 or eotaxin in subjects with and without atherosclerosis.

Original languageEnglish (US)
Pages (from-to)268-274
Number of pages7
JournalAtherosclerosis
Volume183
Issue number2
DOIs
StatePublished - Dec 2005

Fingerprint

Chemokine CCL11
Chemokines
Atherosclerosis
Myocardial Infarction
Angioplasty
Coronary Angiography
Vascular Diseases
Carotid Arteries
Coronary Disease
Immune System
Heart Diseases
Ultrasonography
Enzyme-Linked Immunosorbent Assay
Lipids

Keywords

  • Angiography
  • Chemokine
  • Coronary artery disease
  • Cytokine
  • Immunology

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. / Mosedale, David E.; Smith, Duncan; Aitken, Sri; Schofield, Peter M.; Clarke, Sarah C.; McNab, Duncan; Goddard, Hester; Gale, Catharine R.; Martyn, Christopher N.; Bethell, Hugh W L; Barnard, Caryl; Hayns, Sarah; Nugent, Claire; Panicker, Annik; Grainger, David J.

In: Atherosclerosis, Vol. 183, No. 2, 12.2005, p. 268-274.

Research output: Contribution to journalArticle

Mosedale, DE, Smith, D, Aitken, S, Schofield, PM, Clarke, SC, McNab, D, Goddard, H, Gale, CR, Martyn, CN, Bethell, HWL, Barnard, C, Hayns, S, Nugent, C, Panicker, A & Grainger, DJ 2005, 'Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction', Atherosclerosis, vol. 183, no. 2, pp. 268-274. https://doi.org/10.1016/j.atherosclerosis.2004.11.028
Mosedale, David E. ; Smith, Duncan ; Aitken, Sri ; Schofield, Peter M. ; Clarke, Sarah C. ; McNab, Duncan ; Goddard, Hester ; Gale, Catharine R. ; Martyn, Christopher N. ; Bethell, Hugh W L ; Barnard, Caryl ; Hayns, Sarah ; Nugent, Claire ; Panicker, Annik ; Grainger, David J. / Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction. In: Atherosclerosis. 2005 ; Vol. 183, No. 2. pp. 268-274.
@article{37f0b810a1914e41994d0e1131880c0b,
title = "Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction",
abstract = "The chemokines are a family of signalling proteins that participate in regulation of the immune system and have been implicated in the pathogenesis of vascular diseases. Deleting the gene encoding the chemokine MCP-1 in mouse models of atherosclerosis reduces lipid lesion formation and circulating chemokines are upregulated in man immediately following myocardial infarction (MI) or coronary angioplasty. We have therefore investigated whether circulating levels of two chemokines (MCP-1 and eotaxin) differ between subjects with and without atherosclerosis. We have used three different methods of measuring the presence and extent of atherosclerosis in human subjects: duplex ultrasonography of the carotid arteries and clinical diagnosis of coronary heart disease on individuals from the general population and coronary angiography on patients with suspected heart disease. There was no difference in the levels of circulating MCP-1 or eotaxin, measured by ELISA, between subjects with and without atherosclerosis. Furthermore, any increase in circulating MCP-1 following acute MI must be short-lived, since chemokine levels were not different in subjects who had had an MI previously compared to those who had not. We conclude that although there may be a transient increase in circulating chemokine levels following coronary angioplasty, there is no difference in the levels of circulating MCP-1 or eotaxin in subjects with and without atherosclerosis.",
keywords = "Angiography, Chemokine, Coronary artery disease, Cytokine, Immunology",
author = "Mosedale, {David E.} and Duncan Smith and Sri Aitken and Schofield, {Peter M.} and Clarke, {Sarah C.} and Duncan McNab and Hester Goddard and Gale, {Catharine R.} and Martyn, {Christopher N.} and Bethell, {Hugh W L} and Caryl Barnard and Sarah Hayns and Claire Nugent and Annik Panicker and Grainger, {David J.}",
year = "2005",
month = "12",
doi = "10.1016/j.atherosclerosis.2004.11.028",
language = "English (US)",
volume = "183",
pages = "268--274",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Circulating levels of MCP-1 and eotaxin are not associated with presence of atherosclerosis or previous myocardial infarction

AU - Mosedale, David E.

AU - Smith, Duncan

AU - Aitken, Sri

AU - Schofield, Peter M.

AU - Clarke, Sarah C.

AU - McNab, Duncan

AU - Goddard, Hester

AU - Gale, Catharine R.

AU - Martyn, Christopher N.

AU - Bethell, Hugh W L

AU - Barnard, Caryl

AU - Hayns, Sarah

AU - Nugent, Claire

AU - Panicker, Annik

AU - Grainger, David J.

PY - 2005/12

Y1 - 2005/12

N2 - The chemokines are a family of signalling proteins that participate in regulation of the immune system and have been implicated in the pathogenesis of vascular diseases. Deleting the gene encoding the chemokine MCP-1 in mouse models of atherosclerosis reduces lipid lesion formation and circulating chemokines are upregulated in man immediately following myocardial infarction (MI) or coronary angioplasty. We have therefore investigated whether circulating levels of two chemokines (MCP-1 and eotaxin) differ between subjects with and without atherosclerosis. We have used three different methods of measuring the presence and extent of atherosclerosis in human subjects: duplex ultrasonography of the carotid arteries and clinical diagnosis of coronary heart disease on individuals from the general population and coronary angiography on patients with suspected heart disease. There was no difference in the levels of circulating MCP-1 or eotaxin, measured by ELISA, between subjects with and without atherosclerosis. Furthermore, any increase in circulating MCP-1 following acute MI must be short-lived, since chemokine levels were not different in subjects who had had an MI previously compared to those who had not. We conclude that although there may be a transient increase in circulating chemokine levels following coronary angioplasty, there is no difference in the levels of circulating MCP-1 or eotaxin in subjects with and without atherosclerosis.

AB - The chemokines are a family of signalling proteins that participate in regulation of the immune system and have been implicated in the pathogenesis of vascular diseases. Deleting the gene encoding the chemokine MCP-1 in mouse models of atherosclerosis reduces lipid lesion formation and circulating chemokines are upregulated in man immediately following myocardial infarction (MI) or coronary angioplasty. We have therefore investigated whether circulating levels of two chemokines (MCP-1 and eotaxin) differ between subjects with and without atherosclerosis. We have used three different methods of measuring the presence and extent of atherosclerosis in human subjects: duplex ultrasonography of the carotid arteries and clinical diagnosis of coronary heart disease on individuals from the general population and coronary angiography on patients with suspected heart disease. There was no difference in the levels of circulating MCP-1 or eotaxin, measured by ELISA, between subjects with and without atherosclerosis. Furthermore, any increase in circulating MCP-1 following acute MI must be short-lived, since chemokine levels were not different in subjects who had had an MI previously compared to those who had not. We conclude that although there may be a transient increase in circulating chemokine levels following coronary angioplasty, there is no difference in the levels of circulating MCP-1 or eotaxin in subjects with and without atherosclerosis.

KW - Angiography

KW - Chemokine

KW - Coronary artery disease

KW - Cytokine

KW - Immunology

UR - http://www.scopus.com/inward/record.url?scp=27644476201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644476201&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2004.11.028

DO - 10.1016/j.atherosclerosis.2004.11.028

M3 - Article

VL - 183

SP - 268

EP - 274

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -